4.4 Article

Pharmacological treatment of bipolar disorder and risk of diabetes mellitus: A nationwide study of 30,451 patients

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Endocrinology & Metabolism

Risk of Developing Type 2 Diabetes in Individuals With a Psychiatric Disorder: A Nationwide Register-Based Cohort Study

Nanna Lindekilde et al.

Summary: This study aimed to investigate the incidence of type 2 diabetes in individuals with psychiatric disorders and found that individuals with a psychiatric disorder, especially younger individuals, had a higher incidence rate of type 2 diabetes.

DIABETES CARE (2022)

Review Behavioral Sciences

The prevalence, odds, predictors, and management of tobacco use disorder or nicotine dependence among people with severe mental illness: Systematic review and meta-analysis

Michele Fornaro et al.

Summary: The prevalence, correlates, and management of tobacco use disorder (TUD) or nicotine dependence (ND) among people with severe mental illness (SMI) remain unclear. Rates of TUD/ND co-occurrence are high, especially among males, and while bupropion and varenicline show promise for treating schizophrenia patients with TUD/ND, non-pharmacological interventions require further research, especially for those with primary mood disorders. More well-designed RCTs are needed to inform the management of TUD/ND among people with SMI.

NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2022)

Article Medicine, General & Internal

Type 2 diabetes and risk of diverticular disease: a Danish cohort study

Felix Wittstroem et al.

Summary: The study found that patients with type 2 diabetes had a slightly higher incidence rate of diverticular disease compared to those without diabetes. However, after adjusting for modifiable risk factors, especially BMI, the association between type 2 diabetes and diverticular disease risk appeared to be slightly lower. The lack of adjustment for BMI in previous studies may have contributed to conflicting findings.

BMJ OPEN (2022)

Article Clinical Neurology

Cardiometabolic risk markers during mood-stabilizing treatment: Correlation with drug-specific effects, depressive symptoms and treatment response

Maya Kuperberg et al.

Summary: The study found that patients with bipolar disorder have an increased cardiometabolic risk associated with symptom severity, and treatment with quetiapine can worsen cardiometabolic markers. The results highlight the importance of monitoring cardiometabolic risks during treatment.

JOURNAL OF AFFECTIVE DISORDERS (2022)

Article Psychiatry

Association of Lithium Treatment With the Risk of Osteoporosis in Patients With Bipolar Disorder

Ole Kohler-Forsberg et al.

Summary: This study found an increased risk of osteoporosis in individuals with bipolar disorder. However, treatment with lithium was associated with a decreased risk of osteoporosis, suggesting that bone health should be prioritized in the clinical management of bipolar disorder and further research should be conducted on the potential bone-protective properties of lithium.

JAMA PSYCHIATRY (2022)

Article Medicine, General & Internal

Comparison of Rates of Type 2 Diabetes in Adults and Children Treated With Anticonvulsant Mood Stabilizers

Jenny W. Sun et al.

Summary: In this cohort study, the use of valproate in adults was associated with the highest risk of developing type 2 diabetes (T2D). The comparative safety of anticonvulsant mood stabilizers was generally similar in children, but the estimates were small and variable. Emulating target trials within health care databases can provide important age-specific drug safety data for decision-making.

JAMA NETWORK OPEN (2022)

Article Psychology, Clinical

Treating Insulin Resistance With Metformin as a Strategy to Improve Clinical Outcomes in Treatment-Resistant Bipolar Depression (the TRIO-BD Study): A Randomized, Quadruple-Masked, Placebo-Controlled Clinical Trial

Cynthia Calkin et al.

Summary: This study suggests that metformin, an insulin sensitizer, can reverse insulin resistance and improve clinical outcomes in treatment-resistant bipolar depression. Converters, who no longer met insulin resistance criteria, experienced significant improvements in depression and functioning, and these improvements were sustained up to 26 weeks.

JOURNAL OF CLINICAL PSYCHIATRY (2022)

Article Health Care Sciences & Services

Changes in type 2 diabetes incidence and mortality associated with introduction of HbA1c as diagnostic option: A Danish 24-year population-based study

Jakob S. Knudsen et al.

Summary: Our study findings suggest that introducing HbA1c as a diagnostic option may have changed the basic epidemiology of type 2 diabetes (T2D) and led to some patients going undiagnosed and untreated.

LANCET REGIONAL HEALTH-EUROPE (2022)

Article Clinical Neurology

Pre-diagnostic and post-diagnostic psychopharmacological treatment of 16 288 patients with bipolar disorder

Ole Koehler-Forsberg et al.

Summary: The study described the trends in pre-diagnostic and post-diagnostic psychopharmacological treatment of bipolar disorder over the past two decades in Denmark. The use of two or more antidepressants increased before diagnosis, while the use of lithium decreased and the use of atypical antipsychotics, valproate, and lamotrigine increased after diagnosis. A significant proportion of patients received psychotropic medication post-diagnosis, but a concerning percentage received antidepressants without overlapping mood-stabilizing treatment.

BIPOLAR DISORDERS (2021)

Article Psychiatry

Obesity and metabolic comorbidity in bipolar disorder: do patients on lithium comprise a subgroup? A naturalistic study

Jake Prillo et al.

Summary: Bipolar disorder patients have a high prevalence of obesity and metabolic syndrome, but this is not significantly associated with lithium use. Patients using lithium also have a lower prevalence of type II diabetes compared to those not on lithium. Further research with larger sample sizes is needed to explore the relationship between lithium and insulin resistance.

BMC PSYCHIATRY (2021)

Article Biochemistry & Molecular Biology

Microdose Lithium Protects against Pancreatic Islet Destruction and Renal Impairment in Streptozotocin-Elicited Diabetes

Jiahui Zhang et al.

Summary: Microdose lithium exerts a protective effect on pancreatic islet beta-cells through targeting the GSK3 beta-regulated Nrf2 antioxidant response, ameliorating T1D and its associated kidney impairment.

ANTIOXIDANTS (2021)

Article Physiology

Lithium enhances exercise-induced glycogen breakdown and insulin-induced AKT activation to facilitate glucose uptake in rodent skeletal muscle

Su-Ryun Jung et al.

Summary: The study found that lithium can lower blood glucose levels in T2DM and T1DM animal models by enhancing glucose uptake, as well as enhancing exercise-induced glycogen breakdown and insulin-induced AKT activation.

PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2021)

Review Medicine, Research & Experimental

Real-World Data on the Adverse Metabolic Effects of Second-Generation Antipsychotics and Their Potential Determinants in Adult Patients: A Systematic Review of Population-Based Studies

Miquel Bernardo et al.

Summary: Although there are differences among second-generation antipsychotics in terms of the risk of metabolic disorders, none of the drugs included in the review are completely free of these disturbances. Some studies suggest that the occurrence of a metabolic disorder acts as a risk factor for the development of other metabolic disorders, while treatment duration could also play a relevant role in the occurrence of these disorders.

ADVANCES IN THERAPY (2021)

Review Medicine, General & Internal

Interventions for preventing type 2 diabetes in adults with mental disorders in low- and middle-income countries

Masuma Pervin Mishu et al.

Summary: The prevalence of type 2 diabetes is increased in individuals with mental disorders, especially in low- and middle-income countries. Studies on interventions for the prevention or delay of type 2 diabetes in people with mental illness in LMICs are limited, indicating a need for further research in this area.

COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2021)

Article Clinical Neurology

Long-term metabolic and cardiovascular effects of antipsychotic drugs. A meta-analysis of randomized controlled trials

Francesco Rotella et al.

EUROPEAN NEUROPSYCHOPHARMACOLOGY (2020)

Article Endocrinology & Metabolism

Implication of glycogen synthase kinase 3 in diabetes-associated islet inflammation

Caterina Luana Pitasi et al.

JOURNAL OF ENDOCRINOLOGY (2020)

Article Endocrinology & Metabolism

Diabetes mellitus risk for 102 drugs and drug combinations used in patients with bipolar disorder

Anastasiya Nestsiarovich et al.

PSYCHONEUROENDOCRINOLOGY (2020)

Review Psychiatry

Dietary intake of people with severe mental illness: systematic review and meta-analysis

Scott B. Teasdale et al.

BRITISH JOURNAL OF PSYCHIATRY (2019)

Article Psychology, Clinical

High Prevalence of Metabolic Syndrome Among Adolescents and Young Adults With Bipolar Disorder

Christine Li et al.

JOURNAL OF CLINICAL PSYCHIATRY (2019)

Article Medicine, Research & Experimental

Neuroprotective Lithium Salts Protect Pancreatic β-Cells from Damage

R. U. Ostrovskaya et al.

BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2018)

Review Respiratory System

Prevalence of Comorbid Chronic Obstructive Pulmonary Disease in Individuals Suffering from Schizophrenia and Bipolar Disorder: A Systematic Review

Nicholas Zareifopoulos et al.

COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2018)

Review Psychiatry

Bipolar disorder and diabetes mellitus: evidence for disease-modifying effects and treatment implications

Ellen F. Charles et al.

INTERNATIONAL JOURNAL OF BIPOLAR DISORDERS (2016)

Article Psychiatry

A systematic review and meta-analysis of premature mortality in bipolar affective disorder

J. F. Hayes et al.

ACTA PSYCHIATRICA SCANDINAVICA (2015)

Review Clinical Neurology

Risk factors for suicide in bipolar disorder: A systematic review

Lucas da Silva Costa et al.

JOURNAL OF AFFECTIVE DISORDERS (2015)

Review Pharmacology & Pharmacy

Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases

Eleonore Beurel et al.

PHARMACOLOGY & THERAPEUTICS (2015)

Article Clinical Neurology

Diet quality in bipolar disorder in a population-based-sample of women

Felice N. Jacka et al.

JOURNAL OF AFFECTIVE DISORDERS (2011)

Article Public, Environmental & Occupational Health

The Danish National Prescription Registry

Helle Wallach Kildemoes et al.

SCANDINAVIAN JOURNAL OF PUBLIC HEALTH (2011)

Article Public, Environmental & Occupational Health

The Danish Psychiatric Central Research Register

Ole Mors et al.

SCANDINAVIAN JOURNAL OF PUBLIC HEALTH (2011)

Article Public, Environmental & Occupational Health

The Danish National Patient Register

Elsebeth Lynge et al.

SCANDINAVIAN JOURNAL OF PUBLIC HEALTH (2011)

Article Public, Environmental & Occupational Health

The Danish Civil Registration System

Carsten Bocker Pedersen

SCANDINAVIAN JOURNAL OF PUBLIC HEALTH (2011)

Article Clinical Neurology

The role of valproate in metabolic disturbances in bipolar disorder patients

Hui Hua Chang et al.

JOURNAL OF AFFECTIVE DISORDERS (2010)

Review Endocrinology & Metabolism

Valproate-Induced Insulin Resistance and Obesity in Children

Alberto Verrotti et al.

HORMONE RESEARCH (2009)

Article Psychiatry

Elevated Prevalence of Obesity, Metabolic Syndrome, and Cardiovascular Risk Factors in Bipolar Disorder

Jess G. Fiedorowicz et al.

ANNALS OF CLINICAL PSYCHIATRY (2008)

Article Psychology, Developmental

Weight gain and metabolic effects of mood stabilizers and antipsychotics in pediatric bipolar disorder: A systematic review and pooled analysis of short-term trials

Christoph U. Correll

JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2007)